BioAge Labs
PublicBioAge Labs is now publicly traded
The data on this page reflects BioAge Labs's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Sep 25, 2024
Last Round
Private Placement
Sep 27, 2024
Total Funding Raised
$502.5M
Company Overview
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company founded in 2015 that develops therapeutics for metabolic diseases by targeting the biology of human aging. The company utilizes a proprietary data-driven discovery platform that analyzes human aging data to identify novel drug targets. Its pipeline includes oral small-molecule inhibitors and agonists for conditions such as obesity. After being venture-backed by investors including Andreessen Horowitz and Sofinnova Investments, the company is now publicly traded on the NASDAQ (BIOA).
Sector
Business Products and Services (B2B)
AI Layer
Infrastructure
Keywords
BioAge Labs Comparables
Compare BioAge Labs with similar companies based on industry and business-model similarity.
BioAge Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 27, 2024 | ||||
| IPO | Sep 25, 2024 | ||||
| Series D | Feb 13, 2024 | ||||
| Series C | Dec 3, 2020 | ||||
| Series B | Jan 24, 2019 | ||||
Series A | Jul 28, 2017 |
BioAge Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B, IPO, Series D, Series C |
| Jefferies | IPO |
| Longitude Capital | Series D |
| RA Capital Management | IPO, Series D |
| SV Health Investors | Series D |
| AARP | Series C |
| Lilly Ventures | Series D |
BioAge Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |